{{Rsnum
|rsid=6707600
|Gene=ITSN2
|Chromosome=2
|position=24298897
|Orientation=plus
|GMAF=0.02433
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ITSN2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 2.7 | 97.3
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 6.2 | 93.8
| YRI | 0.0 | 8.9 | 91.1
| ASW | 0.0 | 12.3 | 87.7
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 12.9 | 87.1
| LWK | 0.9 | 10.0 | 89.1
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.6 | 9.6 | 89.7
| TSI | 0.0 | 7.8 | 92.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=0.000003
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Illumina Human 1M}}